Discover the top 30 companies transforming the next-generation sequencing market, including Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., and other industry leaders. Backed by a market projected to grow from $13.81 billion to $27.14 billion by 2031 at a CAGR of 14.5%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.

Download PDF Brochure:“Click Here”

Spotlights on the Industry’s Top Next Generation Sequencing Companies

Illumina, Inc.

Illumina, Inc. is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Headquartered in San Diego, the company’s portfolio includes integrated systems, consumables, and analysis tools that enable large-scale genomic studies. Illumina is renowned for its sequencing-by-synthesis (SBS) technology and its NovaSeq and NextSeq platforms, which power advancements in oncology, reproductive health, and infectious disease monitoring. By focusing on reducing the cost of sequencing and expanding access to genomic data, Illumina remains a primary catalyst for the growth of precision medicine and molecular diagnostics worldwide.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a premier scientific service provider offering an extensive range of technologies for the Next-Generation Sequencing (NGS) market, primarily through its Ion Torrent platform. The company provides end-to-end workflows that include automated library preparation, high-throughput sequencers, and advanced informatics for clinical and research applications. Thermo Fisher’s diagnostic strength is bolstered by its comprehensive portfolio of oncology panels and reproductive health assays. Through strategic acquisitions and a robust global distribution network, the company supports the entire genomic value chain from early-stage discovery to routine clinical implementation.

Agilent Technologies, Inc.

Agilent Technologies, Inc. is a leading provider of analytical and clinical laboratory solutions, with a specialized focus on the NGS workflow through its Diagnostics and Genomics Group. The company is a pioneer in target enrichment and library preparation, offering the industry-standard SureSelect platform to enhance sequencing efficiency. Agilent’s portfolio also includes critical quality control tools, such as the Bioanalyzer and Fragment Analyzer systems, which ensure the integrity of genomic samples. By integrating automation and high-quality reagents, Agilent enables laboratories to streamline complex genomic workflows and achieve high-resolution results in oncology and rare disease research.

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd, headquartered in Switzerland, is a dominant force in the global diagnostics market, leveraging its Roche Diagnostics division to advance genomic science. The company offers a comprehensive suite of NGS solutions, including the AVENIO portfolio for oncology research and liquid biopsy applications. Roche focuses on providing integrated laboratory workflows that combine tissue diagnostics, molecular testing, and digital pathology. Its commitment to personalized healthcare is reflected in its development of companion diagnostics and AI-driven image analysis tools, which help clinicians translate complex genomic data into actionable therapeutic insights.

Danaher Corporation

Danaher Corporation is a global science and technology innovator that serves the NGS market through its diverse portfolio of life sciences companies, including Integrated DNA Technologies (IDT), Beckman Coulter Life Sciences, and Pall Corporation. The company specializes in providing essential tools for genomic research, such as high-quality synthetic oligonucleotides, automated liquid handling systems, and advanced filtration solutions. Danaher’s strategic emphasis on the Danaher Business System (DBS) ensures operational excellence and rapid innovation across its subsidiaries. By supporting critical steps in library preparation and sample processing, Danaher enables high-throughput genomic analysis for academic and biopharmaceutical sectors.

Qiagen

Qiagen is a leading global provider of Sample to Insight solutions, specializing in the extraction and purification of nucleic acids for NGS workflows. The company’s portfolio includes the GeneReader NGS System and an extensive menu of QIAseq panels designed for targeted sequencing in oncology and infectious diseases. Qiagen is particularly recognized for its expertise in bioinformatics and clinical decision support through the QIAGEN Digital Insights platform. By offering automated sample processing and high-performance molecular kits, Qiagen helps laboratories transform biological samples into valuable genomic insights for precision medicine and research.

Revvity

Revvity, formerly part of PerkinElmer, is a science-based solutions provider focused on health science and diagnostics with a strong footprint in the NGS market. The company provides a comprehensive suite of automated library preparation systems, nucleic acid extraction kits, and specialized workflows for newborn screening and prenatal testing. Revvity’s expertise in high-throughput liquid handling and microfluidic technologies supports efficient genomic analysis for clinical and research laboratories. By integrating innovative reagents with scalable automation, Revvity enables its partners to accelerate breakthroughs in genomics and improve patient outcomes through early detection and specialized insights.

Eurofins Scientific

Eurofins Scientific is a global leader in bioanalytical testing, offering an extensive range of NGS services through its specialized genomic divisions. The company provides comprehensive support across the drug development lifecycle, including whole-genome sequencing, exome sequencing, and transcriptomics for pharmaceutical and biotechnology clients. With a vast international network of state-of-the-art laboratories, Eurofins delivers precise and scalable genomic data for applications in agriculture, forensics, and clinical diagnostics. Its expertise in high-throughput testing and custom sequence analysis makes it a vital partner for researchers seeking reliable and rapid genomic insights on a global scale.

Pacbio

Pacbio (Pacific Biosciences of California, Inc.) is a premier developer of high-accuracy sequencing solutions, renowned for its proprietary Single Molecule, Real-Time (SMRT) technology. The company’s platforms, such as the Revio and Sequel systems, provide highly accurate long-read sequencing (HiFi reads), which is essential for de novo assembly, structural variant detection, and full-length RNA sequencing. Pacbio’s technology offers unique insights into complex genomic regions that are often inaccessible to short-read technologies. By focusing on superior data quality and comprehensive genomic coverage, Pacbio empowers researchers to explore the most challenging areas of human, plant, and animal biology.

Oxford Nanopore Technologies PLC

Oxford Nanopore Technologies PLC is a UK-based pioneer in nanopore-based molecular analysis, offering a unique real-time DNA/RNA sequencing technology. The company’s scalable platforms, ranging from the portable MinION to the high-throughput PromethION, enable the analysis of long fragments of native DNA or RNA without the need for PCR amplification. Oxford Nanopore’s technology is characterized by its portability, rapid turnaround times, and ability to detect base modifications simultaneously with sequencing. These features make it a critical tool for diverse applications, including pathogen surveillance, environmental monitoring, and large-scale human genomics.

Takara Bio Inc.

Takara Bio Inc. is a prominent Japanese biotechnology company providing a wide array of reagents and kits for life science research and NGS workflow optimization. The company is a leader in the development of innovative tools for single-cell analysis, cDNA synthesis, and high-fidelity PCR, primarily under the Takara and Clontech brands. Takara’s SMART-seq technology is an industry standard for sensitive and full-length transcriptome analysis from low-input samples. By offering specialized solutions for gene therapy, regenerative medicine, and molecular biology, Takara Bio supports researchers in achieving high-quality genomic data for complex biological studies.

BGI Group

BGI Group is one of the world’s largest genomics organizations, providing comprehensive sequencing services and manufacturing advanced NGS instruments through its subsidiary, MGI Tech. Based in China, BGI offers a vast portfolio of solutions for human, plant, and animal research, as well as clinical applications in reproductive health and oncology. The company is known for its high-throughput DNBSEQ technology, which delivers high-accuracy sequencing with low duplication rates. BGI’s massive data processing capabilities and global network of research centers position it as a key player in international genomic collaborations and large-scale population studies.

BD

Becton, Dickinson and Company (BD) is a global medical technology leader that has significantly impacted the NGS market through its expertise in single-cell analysis and sample preparation. The company’s BD Rhapsody system enables high-throughput single-cell multiomics, allowing researchers to analyze gene expression and protein markers simultaneously at the single-cell level. BD provides integrated workflows that combine flow cytometry with genomic analysis, supporting applications in immunology and oncology research. By focusing on the front-end of the sequencing workflow, BD helps scientists isolate rare cell populations and derive deeper biological insights from complex samples.

10X Genomics

10X Genomics is a leading life sciences technology company that has transformed the NGS market with its innovative Chromium and Visium platforms. The company specializes in single-cell and spatial genomics, providing the tools necessary to analyze biological systems at unprecedented resolution. Its Chromium technology enables high-throughput single-cell sequencing, while the Visium platform allows researchers to map gene expression directly onto tissue images. 10X Genomics’ integrated hardware, chemistry, and software solutions empower scientists to uncover new biological insights in cancer, immunology, and neuroscience by capturing the complexity of individual cells and their environments.

Promega Corporation

Promega Corporation is a global leader in providing innovative solutions and technical support to the life sciences industry, offering a broad range of reagents for NGS sample preparation and quality control. The company’s portfolio includes high-performance kits for nucleic acid extraction, quantitation, and library preparation, as well as specialized tools for monitoring cell health and metabolism. Promega’s expertise in bioluminescence and molecular biology supports the development of sensitive assays for oncology and infectious disease research. By focusing on reliable and easy-to-use reagents, Promega helps laboratories ensure the success of their sequencing runs and the accuracy of their genomic data.

LGC Limited

LGC Limited is an international life sciences tools company that provides mission-critical components and services for the genomic research and diagnostics markets. The company’s genomics division, LGC Biosearch Technologies, offers a comprehensive range of products for NGS, including high-quality oligonucleotides, library preparation kits, and specialized PCR reagents. LGC also provides outsourced genomic services, such as high-throughput genotyping and sequencing, to support the agriculture and biopharmaceutical sectors. By combining technical expertise with a commitment to quality and regulatory compliance, LGC enables its customers to advance research and ensure the safety and efficacy of healthcare products.

Wuxi Biologics

Wuxi Biologics is a leading global Open-access biologics technology platform offering end-to-end solutions for biologics discovery, development, and manufacturing. While primarily a Contract Development and Manufacturing Organization (CDMO), the company utilizes NGS and other advanced genomic technologies to support cell line development, viral clearance testing, and characterization of complex biologics. Wuxi Biologics’ integrated services help biopharmaceutical partners accelerate the development of innovative therapies, including antibody-drug conjugates and gene therapies. Its high-capacity infrastructure and focus on technical innovation make it a critical partner in the global bioprocessing and drug development landscape.

Tecan Trading AG

Tecan Trading AG is a global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company is a leader in laboratory automation, offering specialized platforms such as the Freedom EVO and Fluent systems that are widely used to automate NGS library preparation. Tecan also provides innovative reagents and consumables, including the MagicPrep NGS system, which simplifies and standardizes the library prep process. By focusing on increasing throughput and reducing manual errors, Tecan enables genomic laboratories to scale their operations and achieve more reproducible and efficient sequencing results.

Twist Bioscience

Twist Bioscience is an innovative biotechnology company that has revolutionized the production of synthetic DNA through its proprietary silicon-based manufacturing platform. In the NGS market, Twist is a major provider of high-quality target enrichment panels and library preparation kits. Its DNA synthesis technology allows for the rapid creation of highly uniform and diverse probe sets, which are essential for efficient and cost-effective targeted sequencing in oncology, rare diseases, and population genetics. Twist Bioscience’s commitment to providing scalable and customized genomic tools supports the advancement of precision medicine and synthetic biology research globally.

Azenta US Inc.

Azenta US Inc. (formerly Brooks Life Sciences) is a leading provider of life sciences solutions, offering a comprehensive suite of products and services for sample management and genomic analysis. The company’s genomics division, Azenta Life Sciences, provides high-quality NGS services, including whole-genome, exome, and transcriptome sequencing, as well as specialized services like GLP-compliant sequencing. Azenta also offers industry-leading cold-chain storage and sample tracking solutions, ensuring the integrity of biological samples throughout the research lifecycle. By integrating sample management with advanced genomic services, Azenta helps biopharmaceutical and academic researchers optimize their workflows and accelerate drug discovery.

MGI Tech Co. Ltd.

MGI Tech Co. Ltd., a subsidiary of BGI Group, is a leading manufacturer of high-throughput genetic sequencing instruments and automation systems. The company’s DNBSEQ technology is recognized for its high accuracy and efficiency, supporting a wide range of applications from large-scale population genomics to clinical diagnostics. MGI’s portfolio includes the portable DNBSEQ-E series and the ultra-high-throughput DNBSEQ-T7, as well as automated library preparation and sample processing workstations. By focusing on technological innovation and cost-effective sequencing solutions, MGI Tech aims to build core tools and technology platforms for life science research and personalized healthcare.

Novogene Co., Ltd.

Novogene Co., Ltd. is a leading global provider of genomic services and solutions, with a focus on applying Next-Generation Sequencing and bioinformatics to improve human health. The company operates one of the largest NGS footprints in the world, utilizing advanced platforms from Illumina and Pacbio to deliver high-quality data for research and clinical applications. Novogene’s services include whole-genome sequencing, transcriptomics, epigenomics, and specialized solutions for oncology and microbiology. With a team of expert bioinformaticians and state-of-the-art laboratories in Asia, Europe, and the US, Novogene provides comprehensive and reliable genomic insights to customers in more than 70 countries.

New England Biolabs

New England Biolabs (NEB) is a world leader in the discovery and production of enzymes for molecular biology research, providing essential reagents for every step of the NGS workflow. The company’s NEBNext product line includes a wide range of high-quality library preparation kits for DNA and RNA sequencing, designed to deliver high yields and superior library diversity from a variety of sample types. NEB is renowned for its commitment to scientific excellence and environmental sustainability. By offering innovative tools for sample preparation, target enrichment, and enzymatic fragmentation, NEB supports researchers in achieving high-performance and cost-effective genomic analysis.

Genscript

Genscript is a leading global biotechnology company providing a broad range of life science research and manufacturing services, with a significant presence in the NGS and synthetic biology markets. The company offers specialized services for NGS library preparation, target enrichment, and bioinformatics analysis, supporting applications in drug discovery and clinical research. Genscript is also a world leader in gene synthesis and CRISPR-based genome editing tools, providing the foundational technologies for advanced genomic studies. Its high-quality reagents and customized service models help biopharmaceutical and academic researchers accelerate their projects from initial discovery to commercial development.

Psomagen

Psomagen is a specialized genomic services company that provides high-quality sequencing and analysis solutions to the research and clinical markets. Based in the US and part of the Macrogen group, the company offers a comprehensive suite of NGS services, including whole-genome, exome, and single-cell sequencing. Psomagen is particularly focused on personalized medicine and consumer genomics, providing insights into health, wellness, and ancestry. By leveraging state-of-the-art technology and a team of experienced scientists, Psomagen delivers accurate and timely genomic data that helps researchers and healthcare providers make informed decisions and advance scientific knowledge.

Zymo Research Corporation

Zymo Research Corporation is an innovative biotechnology company specializing in the development of sample collection and nucleic acid purification tools that are critical for the NGS workflow. The company is renowned for its “Direct-Zol” and “Zymo-Spin” technologies, which ensure the highest quality of DNA and RNA from diverse and challenging sample types. Zymo Research also provides specialized services for epigenetics and microbiomics, including the ZymoBIOMICS portfolio for standardized microbiome analysis. By focusing on simplifying and improving the front-end of genomic research, Zymo Research enables scientists to obtain more accurate and representative sequencing results from their biological samples.

Hamilton Company

Hamilton Company is a global leader in the design and manufacture of liquid handling, process analytics, and automated storage solutions. In the NGS market, Hamilton provides high-precision automated workstations, such as the Microlab STAR and VANTAGE lines, which are essential for automating complex library preparation and sample processing workflows. The company’s systems are known for their reliability, flexibility, and ability to handle a wide range of volumes and sample types. By integrating robotics with advanced software, Hamilton enables genomic laboratories to increase throughput, improve data reproducibility, and reduce the manual labor associated with high-scale sequencing projects.

Neogenomics Laboratories

Neogenomics Laboratories is a premier oncology-focused genetic testing company providing comprehensive diagnostic, prognostic, and predictive testing services. The company utilizes Next-Generation Sequencing as a core technology to offer advanced cancer genomic profiles that help oncologists tailor treatments to individual patients. Neogenomics provides a wide range of NGS-based panels for both solid tumors and hematologic malignancies, as well as specialized services for clinical trials and pharmaceutical research. Its commitment to providing high-quality, actionable clinical data and its extensive network of pathologists make it a leading partner in the fight against cancer through precision medicine.

Fulgent Genetics

Fulgent Genetics is a technology-driven genetic testing company that provides a broad array of clinical diagnostic services through its proprietary Next-Generation Sequencing platform. The company specializes in offering comprehensive and customizable genetic tests for a wide range of conditions, including rare diseases, hereditary cancers, and reproductive health. Fulgent’s flexible model allows healthcare providers to choose from a vast menu of genes and panels, supported by rapid turnaround times and competitive pricing. By combining advanced sequencing technology with innovative bioinformatics, Fulgent Genetics aims to make genetic testing more accessible and informative for patients and clinicians worldwide.

SD Biosensor, Inc.

SD Biosensor, Inc. is a global in vitro diagnostics company headquartered in South Korea, specializing in point-of-care testing and innovative molecular diagnostic solutions. While widely known for its rapid diagnostic kits, the company is increasingly active in the genomic space through its development of molecular testing platforms and its expansion into specialized clinical laboratory services. SD Biosensor provides high-quality reagents and instruments for the detection of infectious diseases and other health conditions, leveraging advanced biosensor and molecular biology technologies. Its focus on accessibility and reliable testing supports effective disease management and public health initiatives across global markets.

Download PDF Brochure:“Click Here”